BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27117140)

  • 41. KIT gene mutations and copy number in melanoma subtypes.
    Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
    Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T1799A BRAF mutations in conjunctival melanocytic lesions.
    Goldenberg-Cohen N; Cohen Y; Rosenbaum E; Herscovici Z; Chowers I; Weinberger D; Pe'er J; Sidransky D
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3027-30. PubMed ID: 16123397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
    Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
    Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.
    Tsianakas A; Böhm MR; Getova V; Metze D; Eter N; Spieker T; Bräuninger A; Luger T; Schiller M; Sunderkötter C
    Br J Dermatol; 2013 Jul; 169(1):160-3. PubMed ID: 23464620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.
    Lee JH; Choi JW; Kim YS
    Br J Dermatol; 2011 Apr; 164(4):776-84. PubMed ID: 21166657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low mutational burden of eight genes involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 pathways in female genital tract primary melanomas.
    Pappa KI; Vlachos GD; Roubelakis M; Vlachos DE; Kalafati TG; Loutradis D; Anagnou NP
    Biomed Res Int; 2015; 2015():303791. PubMed ID: 25695059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.
    Alessandrini L; Parrozzani R; Bertorelle R; Valentini E; Candiotto C; Giacomelli L; Midena E; Blandamura S
    Acta Ophthalmol; 2013 Dec; 91(8):e641-5. PubMed ID: 23742652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma.
    Pozzobon FC; Puig-Butillé JA; González-Alvarez T; Carrera C; Aguilera P; Alos L; Badenas C; Grichnik JM; Malvehy J; Puig S
    Br J Dermatol; 2014 Oct; 171(4):754-9. PubMed ID: 24749938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
    Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study.
    Rouzbahman M; Kamel-Reid S; Al Habeeb A; Butler M; Dodge J; Laframboise S; Murphy J; Rasty G; Ghazarian D
    J Low Genit Tract Dis; 2015 Oct; 19(4):350-3. PubMed ID: 26225944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NF1 Mutations Are Common in Desmoplastic Melanoma.
    Wiesner T; Kiuru M; Scott SN; Arcila M; Halpern AC; Hollmann T; Berger MF; Busam KJ
    Am J Surg Pathol; 2015 Oct; 39(10):1357-62. PubMed ID: 26076063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma.
    Yang C; Sanchez-Vega F; Chang JC; Chatila WK; Shoushtari AN; Ladanyi M; Travis WD; Busam KJ; Rekhtman N
    Mod Pathol; 2020 Nov; 33(11):2244-2255. PubMed ID: 32581366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas.
    Fortin Ensign S; Bollin K; Millis SZ; Hinds BR; Kosty M; Uchiyama C
    Pigment Cell Melanoma Res; 2020 May; 33(3):458-465. PubMed ID: 31663661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.
    Küsters-Vandevelde HV; Küsters B; van Engen-van Grunsven AC; Groenen PJ; Wesseling P; Blokx WA
    Brain Pathol; 2015 Mar; 25(2):209-26. PubMed ID: 25534128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi.
    Hawkes JE; Campbell J; Garvin D; Cannon-Albright L; Cassidy P; Leachman SA
    Front Oncol; 2013; 3():160. PubMed ID: 23825798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of
    Emelyanova M; Ghukasyan L; Abramov I; Ryabaya O; Stepanova E; Kudryavtseva A; Sadritdinova A; Dzhumakova C; Belysheva T; Surzhikov S; Lyubchenko L; Zasedatelev A; Nasedkina T
    Oncotarget; 2017 Aug; 8(32):52304-52320. PubMed ID: 28881731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles.
    Koelsche C; Hovestadt V; Jones DT; Capper D; Sturm D; Sahm F; Schrimpf D; Adeberg S; Böhmer K; Hagenlocher C; Mechtersheimer G; Kohlhof P; Mühleisen H; Beschorner R; Hartmann C; Braczynski AK; Mittelbronn M; Buslei R; Becker A; Grote A; Urbach H; Staszewski O; Prinz M; Hewer E; Pfister SM; von Deimling A; Reuss DE
    Brain Pathol; 2015 Mar; 25(2):202-8. PubMed ID: 25399693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation analysis and gene expression profiling of ocular melanomas in cats.
    Rushton JG; Ertl R; Klein D; Nell B
    Vet Comp Oncol; 2017 Dec; 15(4):1403-1416. PubMed ID: 28074614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic Melanocytomas.
    Francis JH; Wiesner T; Milman T; Won HH; Lin A; Lee V; Albert DM; Folberg R; Berger MF; Char DH; Marr B; Abramson DH
    Ocul Oncol Pathol; 2016 Apr; 2(3):171-7. PubMed ID: 27239460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.